The conference will include panels of government regulatory and industry experts discovering current issues surrounding the DQSA’s Title I Compounding Quality Act (CQA) and II Drug Supply Chain Security Act (DSCSA), just four years after being implemented.
Veranstaltungsart: Seminar
- Standort:
- Washington D.C.
- Startdatum / -uhrzeit:
- 15 November 2017
- Enddatum / -uhrzeit:
- 15 November 2017
The conference will also touch on industry updates including, FDA’s Significant Documents and Industry Actions/Reactions on Regulation of Compounding; FDA and Inspections: What to Consider when FDA Visits Your Facility; Licensure of wholesale distributors and 3PL’s: Where does FDA stand, where do states stand, what about VAWD, and what can you do about it?, and so much more.
For a full list of topics, agenda, registration, and additional information please visit fdli.org.